Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Longeveron has expanded and amended its ELA related to Lomecel-B technology rights, and entered into a CRADA with the University of Miami.
read more
10x Genomics announced expansion plans to support the company’s continued growth in Pleasanton across two properties.
read more
Wednesday, March 10, 2021
Baxter Moderna have entered into an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021.
read more
Wednesday, March 10, 2021
Arranta Bio announced the addition of a 130,000-square-foot facility in Boxborough, Massachusetts, to complement its existing facilities.
read more
Wednesday, March 10, 2021
Avacta has announced the AffiDX SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117 variant, as well as the original strain.
read more
Wednesday, March 10, 2021
eMed and Cardinal Health announced a collaboration to distribute millions of at-home COVID-19 rapid tests to pharmacies across the continental United States, Puerto Rico and U.S. Virgin Islands.
read more
Wednesday, March 10, 2021
IONTAS and FairJourney Biologics have announced that they have entered into an agreement with Quell Therapeutics regarding IONTAS / FJB’s proprietary libraries and technology platforms.
read more
Wednesday, March 10, 2021
Cytel has launched East Bayes®, a web-based extension of the East® platform that enables adoption of computationally intensive Bayesian clinical trial designs.
read more
Vectura Group announced an expansion of its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K.
read more
Tergus Pharma has announced the hiring of Heather N. Sugrue as VP of Business Development.
read more
Nonacus announced the commercial launch of a new service for Whole Genome Sequencing of SARS-CoV-2, developed to enable the UK government’s Test-To-Release scheme.
read more
Novartis announced Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company.
read more
Aptamer Group, developer of Optimer™ reagents and therapeutics, has announced the extension of their current agreement with AstraZeneca, a global biopharmaceutical company.
read more
GBG and its CRO arm GD3 has acquired the Berkeley-based CRO Integrated Analytical Solutions.
read more
Debiopharm announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany for the development and commercialization of xevinapant.
read more